For Sale
Serving multiple states across the U.S., this company specializes in providing comprehensive hereditary genetic risk assessment in the areas of cancer, fetal and neonatal, adult and pediatric health.
The Company operates primarily through collaborations with oncology centers, hospitals, and other healthcare facilities, which provide their patient facilities at no cost to the company.
This unique business model allows the company to offer its services in key states, including Kansas, Missouri, California, Idaho,Utah, Alaska, Texas, and Florida, without incurring facility-related expenses.
The workforce is strategically located near these facilities or works virtually, ensuring efficient service delivery and strong local presence.
The company’s focus on hereditary risk assessment in critical health areas positions it as a valuable partner in the healthcare sector. Its growing influence is marked by contracts across several states, indicating a robust expansion and a commitment to delivering specialized genetic risk assessment services.
The company’s approach combines state-of-the-art technology with a deep understanding of genetic risk factors, offering a unique service in the realm of preventive healthcare and personalized medicine.
Revenues and EBITDA have been increasing consistently since 2021 and the business is positioned for significant growth across services and the entire United States.
